Lung cancer (non-small cell)
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Who can joinAdults
Age18–99 years
Kind of studyPhase 2: does it work?
What it testsRadiation and a medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
Tata Memorial HospitalMumbai, MaharashtraDirections ↗
Registry summary (technical)
A Phase II randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic Non-small cell lung cancer patients.
Sponsor: Tata Memorial Hospital
NCT05277844 on ClinicalTrials.gov · CTRI number CTRI/2019/11/021872
Last updated on the registry 10 Sep 2025 · read by us 20 Oct 2026